The purpose of this study is to determine if the screening of nasopharyngeal carcinoma using plasma Epstein-Barr virus DNA analysis would result in the detecting NPC cases at earlier stages and improve survival.
Conditions: Nasopharyngeal Carcinoma
Eligibility Criteria
Inclusion Criteria
- age 40 to 62 years
- ethnic Chinese
- male
Exclusion Criteria
- history of nasopharyngeal carcinoma
- currently having a malignant disease
- active autoimmune disease
- HIV infection
- on systemic steroid treatment
- on immunosuppressant treatment
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年11月5日.